Ling Jin
Impact in
-
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Immune cells in cancer 3
- Atherosclerosis and Cardiovascular Diseases 2
- Co-authors
- Hui‐Hui Yang (6 shared papers)Yong Zhou (8 shared papers)Xiaohua Tan (3 shared papers)Cha‐Xiang Guan (7 shared papers)Yu‐Biao Liu (6 shared papers)Chen‐Yu Zhang (6 shared papers)Xiaoting Huang (1 shared paper)Wenjing Zhong (5 shared papers)
In The Last Decade
Ling Jin
21 papers receiving 387 citations
Peers
Comparison fields: 5 of 79
- Biochemistry 31
- Geriatrics and Gerontology 10
- Biochemistry 14
- Molecular Biology 147
- Urology 11
Countries citing papers authored by Ling Jin
This map shows the geographic impact of Ling Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Jin more than expected).
Fields of papers citing papers by Ling Jin
This network shows the impact of papers produced by Ling Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Jin. The network helps show where Ling Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 68 | |
| 2 | 2023 | 67 | |
| 3 | 2022 | 67 | |
| 4 | 2020 | 30 | |
| 5 | 2022 | 21 | |
| 6 | 2019 | 20 | |
| 7 | 2011 | 19 | |
| 8 | 2023 | 14 | |
| 9 | 2015 | 14 | |
| 10 | 2023 | 13 | |
| 11 | 2024 | 8 | |
| 12 | 2017 | 7 | |
| 13 | Marchantia polymorpha L. Flavonoids Protect Liver From CCl4-Induced Injury by Antioxidant and Gene-Regulatory Effects. | 2022 | 7 |
| 14 | 2024 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2024 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2021 | 2 |
About Ling Jin
Ling Jin is a scholar working on Biochemistry, Immunology, Epidemiology, Biochemistry and Molecular Biology, having authored 21 papers that have together received 391 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Sepsis Diagnosis and Treatment (2 papers), Animal Nutrition and Physiology (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Alcohol Consumption and Health Effects (2 papers) and Biochemical Analysis and Sensing Techniques (1 paper). The work is most often cited by research in Biochemistry (31 citations), Geriatrics and Gerontology (10 citations), Biochemistry (14 citations), Molecular Biology (147 citations) and Urology (11 citations). Ling Jin has collaborated with scholars based in China, Macao and Sweden. Frequent co-authors include Hui‐Hui Yang, Yong Zhou, Xiaohua Tan, Cha‐Xiang Guan, Yu‐Biao Liu, Chen‐Yu Zhang, Xiaoting Huang, Wenjing Zhong, Jia‐Xi Duan and Jia Cao. Their work appears in journals such as Journal of Cellular Physiology, Redox Biology, Histochemistry and Cell Biology, Oral Diseases and BMB Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.